4//SEC Filing
Fowler John Franklin 4
Accession 0001209191-21-069814
CIK 0001645666other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 6:05 PM ET
Size
8.7 KB
Accession
0001209191-21-069814
Insider Transaction Report
Form 4
Fowler John Franklin
Director
Transactions
- Exercise/Conversion
Common Stock
2021-12-14$0.90/sh+7,700$6,930→ 366,904 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-12-14−7,700→ 82,721 totalExercise: $0.90Exp: 2025-09-09→ Common Stock (7,700 underlying)
Holdings
- 38,461(indirect: By LLC)
Common Stock
- 3,750(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The reporting person is a member of Montebello Holdings LLC. The reporting person disclaims Section 16 beneficial ownership of the securities held by Montebello Holdings LLC, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
- [F2]Fully vested.
Documents
Issuer
Kezar Life Sciences, Inc.
CIK 0001645666
Entity typeother
Related Parties
1- filerCIK 0001744263
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 6:05 PM ET
- Size
- 8.7 KB